8 followers
.@Annals_Oncology Phase III RCT (n=316). Adjuvant chemoradiation vs radiation for intermediate-risk post-surgical stage I-IIA cervical cancer showed no significant RFS benefit (HR 0.698, p=0.09). PMID:40947016 https://t.co/lXk66HFDku
Randomized phase III trial of adjuvant radiation versus chemoradiation in intermediate-risk, early-stage cervical cancer following radical hysterectomy and lymphadenectomy: results from NRG Oncology/GO…
Overview of attention for article published in Annals of Oncology, September 2025
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (94th percentile)
-
High Attention Score compared to outputs of the same age and source (85th percentile)
Mentioned by
- news
- 3 news outlets
- 1 X user
- 1 Redditor
- guideline
- 1 clinical guideline source
Readers on
- mendeley
- 22 Mendeley